Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
Marina AtzenhofferMarine AuffretAntoine PegatKamel MasmoudiCharles KhouriBlandine BertinThierry VialPublished in: Clinical drug investigation (2022)
These findings suggest both the absence of safety concern for GBS with mRNA-based COVID-19 vaccines and an increased risk with adenovirus-vectored COVID-19 vaccines. Back to top.